#VisualAbstract: Empagliflozin Has Cardiorenal Benefits for Chronic Kindey Disease
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: chronic kidney disease (CKD)
Prevalence of common chronic conditions in Medicare Advantage and traditional Medicare beneficiaries
1. In this cross-sectional study, Medicare Advantage (MA) beneficiaries had a similar prevalence of obesity, hypertension, hyperlipidemia, and chronic kidney ...
Denosumab may increase risk of major adverse cardiovascular events but reduce fracture risk in patients receiving dialysis
1. In this target trial emulation study, denosumab was associated with an increased risk of major adverse cardiovascular events compared ...
Denosumab increases risk of severe hypocalcemia in women with osteoporosis and chronic kidney disease
1. In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as ...
Rosuvastatin may reduce risk of all-cause mortality and major adverse cardiovascular events compared with atorvastatin
1. In this multi-database retrospective cohort study, rosuvastatin was found to be associated with slightly decreased risk of all-cause mortality ...
#VisualAbstract: Semaglutide Improves Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Sodium bicarbonate does not prevent declining kidney function in kidney transplant recipients
1. The mean eGFR slope was comparable among patients allocated to sodium bicarbonate and placebo over 24 months. 2. Sodium ...
Cystatin C-based equation without race or sex improves accuracy of GFR estimation
1. In this cross-sectional study, serum cystatin C levels were similar in both Black and White patients at the same ...
Dapagliflozin reduces the risk of hospitalization in patients with chronic kidney disease
1. Dapagliflozin reduced the risk of hospitalization in patients with chronic kidney disease (CKD) with and without type 2 diabetes ...
#VisualAbstract: Continuation of renin–angiotensin system inhibitors does not impact disease progression in those with advanced chronic kidney disease
Click here to read this study in NEJM